From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer’s disease

From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer’s disease

<p dir="ltr">Type 2 Diabetes (T2D) and Alzheimer’s Disease (AD) share common risk factors that can be seen through T2D nearly doubling an individual’s likelihood of developing AD. Some AD patients show signs of metabolic dysfunction as well. This review focuses on the potential mecha...

Full description

Saved in:

Bibliographic Details
Main Author:	Ahmad Raza (18205961) (author)
Other Authors:	Shafaq Saleem (22934654) (author), Samar Imran (22997221) (author), Sarah Rahman (4568125) (author), Muhammad Haroon (7830661) (author), Azeen Razzaq (22997224) (author), Ahmad Hussain (22997227) (author), Javed Iqbal (2121922) (author), Brijesh Sathian (479264) (author)
Published:	2025
Subjects:	Biomedical and clinical sciences Medical biochemistry and metabolomics Neurosciences Type 2 diabetes mellitus (T2D) Alzheimer’s disease (AD) Insulin resistance Amyloid-beta (Aβ) accumulation Advanced glycation end products (AGEs) Neuroinflammation Mitochondrial dysfunction
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease
by: Abolaji Samson Olagunju (16855185)
Published: (2023)

Glycation in Alzheimer’s Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions
by: Sama Ayoub (15430987)
Published: (2025)

Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease
by: Sanaa Sharari (12561952)
Published: (2023)

Lewy body pathology is more prevalent in older individuals with mitochondrial disease than controls
by: Daniel Erskine (3471959)
Published: (2019)

Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension
by: Yousef, Hibba
Published: (2023)

Exploratory risk prediction of type II diabetes with isolation forests and novel biomarkers
by: Yousef, Hibba
Published: (2024)

Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice
by: Ann Van der Jeugd (18629695)
Published: (2018)

Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia
by: Abu Saleh Md Moin (6189512)
Published: (2021)

Protein Glycation in Plants—An Under-Researched Field with Much Still to Discover
by: Naila Rabbani (291722)
Published: (2020)

Anti-amyloid monoclonal antibody therapies in Alzheimer’s disease – a scoping review
by: Shahd Abubaker Elamin (22569539)
Published: (2025)

Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer’s disease-related dysregulation
by: Larissa Haertle (3864310)
Published: (2019)

Klotho overexpression protects human cortical neurons from β-amyloid induced neuronal toxicity
by: Mohammed R. Shaker (10316180)
Published: (2025)

The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis—A Preliminary Report
by: Noothan Satheesh (18595729)
Published: (2021)

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders
by: Vasilios C. Constantinides (18595828)
Published: (2021)

Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline
by: Hanan Ehtewish (17149825)
Published: (2022)

Endocrine contribution to the sexual dysfunction in patients with advanced chronic kidney disease and the role of hyperprolactinemia
by: Haitham Elbardisi (14058048)
Published: (2021)

Western diet induces mild metabolic impairment and aggravates neuropathology in an experimental mouse model of traumatic brain injury
by: Judith, Nwaiwu
Published: (2024)

AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
by: Naila Rabbani (291722)
Published: (2022)

The impact of chronic fentanyl administration on the cerebral cortex in mice: Molecular and histological effects
by: Ayman Alzu'bi (18192898)
Published: (2024)

Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal
by: Zehra Irshad (18614869)
Published: (2019)

Decision-level fusion for single-view gait recognition with various carrying and clothing conditions
by: Al-Tayyan, Amer
Published: (2017)

Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease
by: Sudharsana Sundarrajan (3181371)
Published: (2023)

The role of dietary antioxidants in type 2 diabetes and neurodegenerative disorders: An assessment of the benefit profile
by: Munazza Tamkeen Fatima (17316955)
Published: (2022)

Neurodegenerative disorders
by: Riachi, Naji J.
Published: (1989)

Leveraging hallmark Alzheimer’s molecular targets using phytoconstituents: Current perspective and emerging trends
by: Prajakta A. Dhage (17302789)
Published: (2021)

Potential immunomodulatory role of sesamin in combating immune dysregulation associated with COVID-19
by: Majdalawieh, Amin
Published: (2021)

Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition: a validation study
by: Jonas Ellegaard Nielsen (21633062)
Published: (2024)

A New Data-Based Dust Estimation Unit for PV Panels
by: Shaaban, Mostafa
Published: (2020)

An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes
by: Anns Mahboob (17337886)
Published: (2023)

Evaluation of Neuro Images for the Diagnosis of Alzheimer's Disease Using Deep Learning Neural Network
by: Ahila A (18394806)
Published: (2022)

Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): a systematic review and meta-analysis
by: Dr. Rasha Kaddoura (17823428)
Published: (2024)

Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models
by: Enrico Faldini (18602953)
Published: (2019)

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
by: Nour K. Majbour (8809316)
Published: (2017)

An Exemplar Pyramid Feature Extraction Based Alzheimer Disease Classification Method
by: Heba Soliman Zaina (16904787)
Published: (2022)

Characterization of Dust Accumulation and Its Effect on the Performance of Photovoltaic Cells
by: Qaisieh, Alaa Moh’d
Published: (2022)

Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
by: Naila, Rabbani
Published: (2021)

Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle
by: Jinit, Masania
Published: (2023)

Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
by: Megan F. Duffy (5713772)
Published: (2018)

Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
by: Megan F. Duffy (5713772)
Published: (2018)

The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
by: Bara A. Shraim (11753786)
Published: (2021)